Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months’ Remission with Lapatinib plus Capecitabine

Breast tumors overexpressing Her2 (15% of breast cancers) are particularly at risk for central nervous system parenchymal metastases. Whole-brain irradiation (WBI) is the standard of care of brain metastases (BM), and secondarily, systemic treatment is used in case of progression. We report the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Mailliez, Audrey, Servent, Véronique, Bonneterre, Jacques, Le Rhun, Emilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: August, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164102/
https://www.ncbi.nlm.nih.gov/pubmed/25232326
http://dx.doi.org/10.1159/000365747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164102/
https://www.ncbi.nlm.nih.gov/pubmed/25232326
http://dx.doi.org/10.1159/000365747

Ejemplares similares